#Germany #Munich #lab solutions #analytica 2026 #Haier Biomedical

Haier Biomedical at analytica 2026

Haier Biomedical, a leading global player in medical biological sciences and healthcare solutions, made a significant impact at the analytica 2026 trade fair held in Munich, Germany. The event was themed "In Europe, for Europe," highlighting the company's strategic focus on localization throughout the continent. This approach is bolstered by a network of regional offices and recent successes in crucial European markets.

As Haier Biomendical transforms from a traditional equipment supplier to a comprehensive solutions provider, it showcased its full range of lab offerings, designed for biobanks, research labs, and pharmacies. Their solutions cover the entire lifecycle of sample management, including collection, storage, monitoring, and control.

At the exhibition, Haier Biomedical unveiled an array of essential equipment for biomedical research. Highlights include cutting-edge CO₂ incubators, biosafety cabinets, centrifuges, pharmaceutical refrigerators, liquid nitrogen containers, autoclaves, and the newly launched shaker-incubators. These incubators feature continuous operation modes and precise temperature control, ideal for cultivating cell suspensions. Additionally, the company introduced a sublimation dryer, designed for effective sample drying.

One of the standout innovations was the UltraEco ULT Freezer series, equipped with Eco-Drive technology, which boasts 30% higher efficiency than typical industry standards. Alongside biobanking solutions, Haier Biomedical now offers fully integrated and automated workflows, addressing the real-world challenges of maintaining sample integrity, operational efficiency, and data traceability.

The company's definition of globalization extends beyond simple product export; it involves establishing and deepening local market presence. By implementing a "one country, one strategy" approach, Haier Biomedical has built localized operational frameworks across 18 countries, acquiring over 400 domestic product certifications in the process. Furthermore, local employees now account for more than 40% of its workforce.

This strategic move has secured Haier Biomedical a leadership position among Chinese brands in market share across six countries. In Italy, they are setting up a subsidiary to enhance their local service support for industry users, aiming to boost the overall value of their offerings in the region.

In the UK, Haier Biomedical successfully delivered a turnkey solution involving 64 specialized biosafety cabinets to Queen Mary University of London within 24 hours. In Italy, they supplied a local hospital with an intelligent blood inventory management system, U-Blood, showcasing a smart solution for managing blood supplies within the European healthcare system. In Germany, leading universities received cryogenic freezers operating at -150°C, along with BPST ULT freezers, which utilize hydrocarbon refrigerant technology to enhance both safety and operational efficiency in research environments.

The analytica 2026 exhibition marks a pivotal shift for Haier Biomedical. Moving away from purely exporting products, the company is committed to co-creating an ecosystem in medical biological sciences. Their model, which integrates technology, local presence, and ecosystem development, positions Haier Biomedical for deeper engagement within the European market while leveraging local capacities for global expansion.

As they look to the future, Haier Biomedical remains dedicated to strengthening their foothold in Europe, aspiring to become a trusted brand in medical biological sciences for users worldwide. For additional information, you can visit Haier Biomedical.

Video 1 | Video 2